On June 14, 2016, the Court of Appeals for the Federal Circuit issued its opinion in the patent case Genzyme Therapeutic Products v. Biomarin Pharmaceutical, docket number 15-1720. Judge Bryson wrote for the three-judge panel. The case was appealed from an inter partes review proceeding before the United States Patent Trial and Appeals Board (PTAB). The patents at issue were US patents 7351410 and 7655226, both of which are directed.. Read More